US FDA lifts clinical hold on Intellia's heart disease gene therapy trial
US FDA lifts clinical hold on Intellia's heart disease gene therapy trial
ReutersMon, March 2, 2026 at 12:40 PM UTC
0
FILE PHOTO: Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kell//File Photo
March 2 (Reuters) - Intellia Therapeutics said on Monday the U.S. Food and Drug Administration has removed a clinical hold on the late-stage clinical trial for its experimental gene therapy for a heart disease.
Advertisement
(Reporting by Christy Santhosh in Bengaluru; Editing by Leroy Leo)
Source: “AOL Breaking”
